Funding
Turn ideas into impact
Show Me
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk
US $275,000
Type
Grant
Source
Federal
Due: January 7, 2028
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-315
Due: January 7, 2028
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-124
Due: January 7, 2028
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-273
Due: January 7, 2028
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
US $500,000
Type
Grant
Source
Federal
Opp Number
PAR-25-175
Due: January 7, 2028
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-143
Due: January 7, 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Not Allowed)
US $499,000
Type
Grant
Source
Federal
Opp Number
PAR-25-338
Due: January 7, 2028
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PA-25-301
Due: January 7, 2028
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-282
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?